. 2020 Jun 4;12(6):1469. doi: 10.3390/cancers12061469

Table 3.

Univariate and multivariate analyses of progression-free prognostic factors in patients with cervical cancer.

Factors	Patients	Univariate Analysis			Multivariate Analysis
		Hazard Ratio	95% CI	p-Value	Hazard Ratio	95% CI	p-Value
Age
<57	34	1.4	0.44–4.68	0.56	NA	NA	NA
≥57	29	1.4	0.44–4.68	0.56	NA	NA	NA
FIGO stage
I, IIA	15	3.77	1.19–11.92	0.023	1.95	0.56–6.78	0.28
IIB, III, & V	48	3.77	1.19–11.92	0.023	1.95	0.56–6.78	0.28
Histology
SCC	33	1.09	0.35–3.39	0.87	NA	NA	NA
AC/ASC	30	1.09	0.35–3.39	0.87	NA	NA	NA
RLT
long	34	6.88	1.80–26.27	0.005	5.17	1.21–22.06	0.02
Short	29	6.88	1.80–26.27	0.005	5.17	1.21–22.06	0.02

AC, adenocarcinoma; ASC, adenosquamous carcinoma; RLT, CI, confidence interval; FIGO, International Freedom of Gynecology and Obstetrics; RLT, relative lymphocyte telomere length; SCC, squamous cell carcinoma.